Quick Dispatch:
Your foxo4-dri peptide senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your foxo4-dri peptide senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI ships.
Need Help?
Questions about foxo4-dri peptide senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for foxo4-dri peptide senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI in your area.
Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis
29.77
Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis
28.90
Frontiers
29.78
FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation
21.92
Peptide inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis
22.02
Frontiers
21.73
(PDF) Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes
26.42
